Abeona Therapeutics (ABEO) Enterprise Value Growth (3y) (2013 - 2026)
Abeona Therapeutics (ABEO) Enterprise Value Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -67.17% |
| Dec 31, 2025 | -53.92% |
| Sep 30, 2025 | -125.19% |
| Jun 30, 2025 | -123.88% |
| Mar 31, 2025 | -70.83% |
| Dec 31, 2024 | -24.42% |
| Sep 30, 2024 | -17.42% |
| Jun 30, 2024 | -4.11% |
| Mar 31, 2024 | 19.88% |
| Dec 31, 2023 | 18.19% |
| Sep 30, 2023 | 17.65% |
| Jun 30, 2023 | 29.93% |
| Mar 31, 2023 | 32.29% |
| Dec 31, 2022 | 25.95% |
| Sep 30, 2022 | 27.63% |
| Jun 30, 2022 | 31.50% |
| Mar 31, 2022 | 37.25% |
| Dec 31, 2021 | 15.69% |
| Sep 30, 2021 | 15.39% |
| Jun 30, 2021 | 13.14% |